{
    "Trade/Device Name(s)": [
        "SAFECARE\u00ae THC Urine Strip Test"
    ],
    "Submitter Information": "Safecare Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K191924",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153646"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFW"
    ],
    "Summary Letter Date": "August 16, 2019",
    "Summary Letter Received Date": "July 18, 2019",
    "Submission Date": "August 15, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "11-nor-\u03949-THC-9 COOH",
        "Marijuana metabolites",
        "11-Hydroxy-9-Tetrahydrocannabinol",
        "11-Nor-8-Tetrahydrocannabinol-9-COOH",
        "Cannabinol",
        "8-Tetrahydrocannabinol",
        "\u03949-Tetrahydrocannabinol",
        "Cannabidiol",
        "11-Nor-\u22069-THC-carboxy glucuronide",
        "(-)-11-nor-9-carboxy-\u22069-THC"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Individual containers"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for SAFECARE\u00ae THC Urine Strip Test, a lateral flow immunochromatographic assay for qualitative detection of marijuana metabolites in human urine",
    "Indications for Use Summary": "Qualitative detection of marijuana (11-nor-\u03949-THC-9 COOH) in human urine at a cutoff concentration of 50 ng/mL for preliminary over-the-counter use",
    "fda_folder": "Toxicology"
}